Livongo Health is preparing for a $1 billion initial public offering this year, according to a new report from The Wall Street Journal.
The IPO for the Mountain View, Calif.-based diabetes-focused digital health company is set to drop in the third quarter of this year, according to the report.
Livongo tapped Morgan Stanley, Goldman Sachs Group and JPMorgan Chase & Co. as underwriters for the offering, according to The Wall Street Journal.
The company has raised approximately $240 million so far, and was recently given an $800 million valuation, according to the report.
Last September, Livongo Health said that it now integrates continuous glucose data from Abbott‘s (NYSE:ABT) FreeStyle Libre Pro system into its Livongo for Diabetes system, touting it as the first such system to integrate data from Abbott’s FreeStyle Libre Pro.